The anti-cancer effect of shikonin is mainly achieved by the inhibition of malignant cell growth and the induction of caspase-3-dependent apoptosis, DNA cleavage, and cell cycle arrest, likely through its accumulation in mitochondria and alteration of cellular Ca2+ and reactive oxygen species (ROS) [39,42,43,44]. The gene discussed is CASP3; the disease is cancer.